Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2017.
Dear Sir, Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate submitted by Mr. Ravindra V. Joshi, Practicing Company Secretary, for the half year ended March 31, 2017. Standalone Financial Results, Limited Review Report for December 31, 2016
Veerhealth Care Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016 Outcome of Board Meeting
Veerhealth Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 10, 2017, inter alia, has decided the following;1. The Board of Directors have considered resignation of Mr. Jigar Shah from the post of Chief Financial Officer of the Company and accepted said resignation with immediate effect.2. The Board of Directors have appointed Mr. Akash Shah as Chief Financial Officer of the Company with effect from February 10, 2017. Board Meeting Intimation for Results & Closure of Trading Window
Veerhealth Care Ltd has informed BSE regarding "Board Meeting Intimation for Results & Closure of Trading Window". Shareholding for the Period Ended December 31, 2016
Veerhealth Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Veerhealth Care Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Fixes Record Date for Consolidation of equity shares
Veerhealth Care Ltd has informed BSE that the Company has fixed November 30, 2016 as the Record Date for the purpose of Consolidation of Re. 1/- per share of the Company into the shares of Rs. 10/- each. Standalone Financial Results, Limited Review Report for September 30, 2016
Veerhealth Care Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016 Board Meeting on Nov 12, 2016
Veerhealth Care Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on November 12, 2016 inter alia, to transact the following business:1. To consider, adopt and take on record the quarterly unaudited results of the Company for the quarter ended September 30, 2016.2. To fix the record date for Consolidation of Equity Shares of the Company from Re. 1/- to Rs.10/- per share.... Shareholding for the Period Ended September 30, 2016
Veerhealth Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here